Seres Therapeutics (MCRB) Assets (2014 - 2026)
Seres Therapeutics (MCRB) posted Assets of $117.6 million for Q1 2026, down 14.89% sequentially from $138.2 million in Q4 2025, and down 28.36% YoY from $164.2 million in Q1 2025.
Seres Therapeutics (MCRB) Assets (2014 - 2026) Analysis & Trends
Seres Therapeutics has reported Assets for 13 years, with the latest figure at $117.6 million in Q1 2026.
- Quarterly Assets fell 28.36% year-over-year to $117.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $117.6 million (down 28.36% YoY) and the FY2025 annual result came in at $138.2 million, down 1.16% from the prior year.
- Assets retreated to $117.6 million in Q1 2026 per MCRB's latest filing, from $138.2 million in the prior quarter.
- Over five years, Assets peaked at $406.4 million in Q2 2023 and troughed at $117.6 million in Q1 2026.
- A 5-year average of $255.6 million and a median of $273.2 million in 2022 frame the typical range for Assets.
- The sharpest annual moves came in 2023 and 2024: Assets jumped 48.75% in 2023, then plunged 61.01% in 2024.
- Over 5 years, Assets stood at $348.8 million in 2022, then gained by 2.81% to $358.6 million in 2023, then tumbled by 61.01% to $139.8 million in 2024, then dropped by 1.16% to $138.2 million in 2025, then decreased by 14.89% to $117.6 million in 2026.
- According to Business Quant data, Assets over the past three periods registered $117.6 million, $138.2 million, and $143.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.76 Bn | 130.91 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 86.15 Bn | 78.15 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.45 Bn | 59.27 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 57.08 Bn | 51.94 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 42.08 Bn | 36.99 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 30.90 Bn | 27.59 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 27.76 Bn | 9.37 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.45 Bn | 26.29 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.00 Bn | 26.17 Bn | - | 19.82 Bn |
| 10 | Seres Therapeutics | 44.45 Mn | 44.45 Mn | - | 101.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 101.59 Mn |
| Mar 31, 2026 | 117.62 Mn |
| Dec 31, 2025 | 138.19 Mn |
| Sep 30, 2025 | 143.47 Mn |
| Jun 30, 2025 | 143.80 Mn |
| Mar 31, 2025 | 164.18 Mn |
| Dec 31, 2024 | 139.81 Mn |
| Sep 30, 2024 | 178.74 Mn |
| Jun 30, 2024 | 321.73 Mn |
| Mar 31, 2024 | 341.26 Mn |
| Dec 31, 2023 | 358.60 Mn |
| Sep 30, 2023 | 367.70 Mn |
| Jun 30, 2023 | 406.39 Mn |
| Mar 31, 2023 | 270.19 Mn |
| Dec 31, 2022 | 348.78 Mn |
| Sep 30, 2022 | 311.87 Mn |
| Jun 30, 2022 | 273.20 Mn |
| Mar 31, 2022 | 319.89 Mn |
| Dec 31, 2021 | 354.86 Mn |
| Sep 30, 2021 | 396.29 Mn |